Cambria Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Cambria Investment Management's LLY Position: Q1 2026 in Review
Cambria Investment Management reduced its Eli Lilly (LLY) stake by 6.6% in Q1 2026, selling an estimated $152K and leaving 2,120 shares worth $1.95M. The position accounts for 0.11% of the portfolio, ranked #165.
Cambria Investment Management first reported a position in LLY in Q4 2014 and has held it in 17 quarters since. The position peaked at $5.95M in Q4 2017. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Cambria Investment Management held 2,120 shares of Eli Lilly worth $1.95M as of Q1 2026.
- Cambria Investment Management sold 150 Eli Lilly shares in Q1 2026, an estimated $152K.
- Eli Lilly made up 0.11% of Cambria Investment Management's portfolio in Q1 2026, its #165 holding.
- Cambria Investment Management first reported a position in Eli Lilly in Q4 2014 and has held it in 17 quarters since.
- Cambria Investment Management's Eli Lilly position peaked at $5.95M in Q4 2017.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.